I am pretty damn sure Dew didn't say buy ENTA at $100 then hold it for the rest for your life. Dew was talking about ENTA well before it jumped dramatically to over $100. I read about it and bought it when it was in the $20-$30 range. I ended up selling some in the $80s and $90s. I though their Hepatitis B and Covid programs had promise so when it dropped dramatically I started buying more. I have more shares than I ever did, and by a lot. I am down 60% right now but still have hopes with the RSV program and for stubborn reasons have a dream that EDP-235 (their anti-Covid protease inhibitor) isn't yet dead. One of their 2 HepB drugs (EDP-514) looked promising but they need another one to generate a marketable product. They are getting developing a Kit drug too. It is called high risk, high reward.